Literature DB >> 8952520

Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions.

K Nakazato1, T Ishibashi, J Shindo, M Shiomi, Y Maruyama.   

Abstract

The expression of very low density lipoprotein (VLDL) receptor mRNA in atherosclerotic lesions in rabbits was investigated. To examine the expression of the VLDL receptor in the vascular wall, poly(A)+ RNA was isolated from whole aortas of cholesterol-fed New Zealand White (NZW), Watanabe heritable hyperlipidemic (WHHL), and normal NZW rabbits, and then Northern blot analysis was performed. The VLDL receptor mRNA was detected in aortas from both NZW rabbits fed 0.5% cholesterol for 16 weeks and 12-month-old WHHL rabbits, whereas no expression was seen in normal NZW rabbit aortas. To further determine the localization of the VLDL receptor mRNA, in situ hybridization using digoxigenin-labeled riboprobes and immunohistochemistry using monoclonal antibodies against each cell component were performed. Early atherosclerotic lesions, termed fatty streaks, in the NZW rabbits fed 0.5% cholesterol for 4 weeks demonstrated strong expression of the VLDL receptor mRNA by macrophages. The VLDL receptor mRNA was also expressed in more advanced atherosclerotic lesions from both atherogenic animal models. The predominant origin of the VLDL receptor mRNA-positive cells was macrophages, and some intimal smooth muscle cells appeared to express a weak but significant signal in these advanced lesions. Our findings suggest that the VLDL receptor expression may play a role in the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8952520      PMCID: PMC1865343     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition.

Authors:  J L Goldstein; Y K Ho; S K Basu; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 4.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

Review 6.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

Authors:  M S Brown; J L Goldstein
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

7.  The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein.

Authors:  U Beisiegel; W Weber; G Ihrke; J Herz; K K Stanley
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

8.  Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit.

Authors:  T Tsukada; M Rosenfeld; R Ross; A M Gown
Journal:  Arteriosclerosis       Date:  1986 Nov-Dec

9.  Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.

Authors:  S Takahashi; J Suzuki; M Kohno; K Oida; T Tamai; S Miyabo; T Yamamoto; T Nakai
Journal:  J Biol Chem       Date:  1995-06-30       Impact factor: 5.157

10.  A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.

Authors:  O Skalli; P Ropraz; A Trzeciak; G Benzonana; D Gillessen; G Gabbiani
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  6 in total

1.  Apolipoprotein E induces antiinflammatory phenotype in macrophages.

Authors:  Daniel Baitsch; Hans H Bock; Thomas Engel; Ralph Telgmann; Carsten Müller-Tidow; Georg Varga; Martine Bot; Joachim Herz; Horst Robenek; Arnold von Eckardstein; Jerzy-Roch Nofer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-02-24       Impact factor: 8.311

2.  Lapaquistat acetate, a squalene synthase inhibitor, changes macrophage/lipid-rich coronary plaques of hypercholesterolaemic rabbits into fibrous lesions.

Authors:  M Shiomi; S Yamada; Y Amano; T Nishimoto; T Ito
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

Review 3.  The very low density lipoprotein (VLDL) receptor--a peripheral lipoprotein receptor for remnant lipoproteins into fatty acid active tissues.

Authors:  Sadao Takahashi; Juro Sakai; Takahiro Fujino; Isamu Miyamori; Tokuo T Yamamoto
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

Review 4.  Lipoprotein receptor signalling in atherosclerosis.

Authors:  Chieko Mineo
Journal:  Cardiovasc Res       Date:  2020-06-01       Impact factor: 10.787

Review 5.  Hypoxia-inducible factors as essential regulators of inflammation.

Authors:  Hongxia Z Imtiyaz; M Celeste Simon
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 6.  Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.

Authors:  Sadao Takahashi
Journal:  J Atheroscler Thromb       Date:  2017-04-19       Impact factor: 4.928

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.